Abstract

The widespread use of neonicotinoid insecticides has sparked concern over the toxicity risk to honey bees (Apis mellifera L. (Hymenoptera: Apidae)). In this study, feeding treatments with the clothianidin formulation at 2.6 ppb (residue concentration) or its binary mixtures with five representative pesticides (classes) did not influence on adult survivorship, but all treatments caused significantly lower body weight than controls. Most binary mixtures at residue levels showed minor or no interaction on body weight loss, and synergistic interaction was detected only from the mixture of clothianidin + λ-cyhalothrin. Chlorpyrifos alone and the mixture of clothianidin + chlorpyrifos significantly suppressed esterase (EST) activity, while most treatments of individual pesticides and mixtures had no effect on EST and glutathione S-transferase (GST) activities. However, ingestion of clothianidin at 2.6 ppb significantly enhanced P450 oxidase activity by 19%. The LC50 of formulated clothianidin was estimated at 0.53 ppm active ingredient, which is equivalent to 25.4 ng clothianidin per bee (LD50) based on the average sugar consumption of 24 µl per bee per day. In addition to mortality, ingestion of clothianidin at LC50 significantly reduced bee body weight by 12%. P450 activities were also significantly induced at 24 and 48 h in clothianidin-treated bees, while no significant difference was found in GST and EST activities. Further examinations revealed that the expression of an important CYP9q1 detoxification gene was significantly induced by clothianidin. Thus, data consistently indicated that P450s were involved in clothianidin detoxification in honey bees. Although the honey bee population in Stoneville (MS, United States) had sixfold lower susceptibility than other reported populations, clothianidin had very high oral toxicity to bees.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.